Evidence map›Paper›PMID 40695730›Full record

ArticleTropical medicine & international health : TM & IH2025

High Burden of Symptomatic and Asymptomatic Sexually Transmitted Infections in a Routine Decentralised HIV Care Setting in Eswatini: A Cross-Sectional Study.

Bernhard Kerschberger, Nombuso Ntshalintshali, Mano Isaac Mafomisa, Edwin Mabhena, Michelle Daka, Esther Mukooza, Skinner Lekelem, Sindisiwe Dlamini, Mpumelelo Mavimbela, Lenhle Dube and 10 more

Abstract readMulticenter Study
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Bernhard KerschbergerMédecins Sans Frontières (MSF), Mbabane, Eswatini.ORCID https://orcid.org/0000-0003-0525-7262
Nombuso NtshalintshaliMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Mano Isaac MafomisaMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Edwin MabhenaMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Michelle DakaMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Esther MukoozaMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Skinner LekelemMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Sindisiwe DlaminiNational Reference Laboratory (NRL), Ministry of Health, Mbabane, Eswatini.
Mpumelelo MavimbelaEswatini National AIDS Programme (ENAP), Ministry of Health, Mbabane, Eswatini.
Lenhle DubeEswatini National AIDS Programme (ENAP), Ministry of Health, Mbabane, Eswatini.
Sindy MatseEswatini National AIDS Programme (ENAP), Ministry of Health, Mbabane, Eswatini.
Nomvuyo MabuzaNational Reference Laboratory (NRL), Ministry of Health, Mbabane, Eswatini.
Roberto de LatourMédecins Sans Frontières (MSF), Geneva, Switzerland.
Laurence Toutous TrelluUniversity Hospital of Geneva, Geneva, Switzerland.
Hayk KarakozianMédecins Sans Frontières (MSF), Mbabane, Eswatini.
Nelly StaderiniMédecins Sans Frontières (MSF), Geneva, Switzerland.
Melat HaileMédecins Sans Frontières (MSF), Geneva, Switzerland.
Pablo ValladaresMédecins Sans Frontières (MSF), Geneva, Switzerland.
Alexandra CalmyUniversity Hospital of Geneva, Geneva, Switzerland.
Iza CigleneckiMédecins Sans Frontières (MSF), Geneva, Switzerland.

Funding

Médecins Sans Frontières
6 · The paper itself

Abstract

objectivesSexually transmitted infections are a global public health concern. We aimed to assess the burden of a diverse range of sexually transmitted infections in a high HIV burden setting in Eswatini and associated risk factors.

methodsThis cross-sectional study enrolled adults accessing routine outpatient care at six sites in Shiselweni, from July 2022 to April 2023. Laboratory investigations included antibody-based tests for HIV, Treponema pallidum , hepatitis B, hepatitis C, and herpes simplex 2 viruses. The molecular-based Xpert platform tested urine samples for Chlamydia trachomatis , Neisseria gonorrhoea, Trichomonas vaginalis, self-collected vaginal/anal swabs for Human papillomavirus, and plasma for HIV viremia. We calculated the proportion of laboratory-confirmed sexually transmitted infections among available test results and identified predictors of combined Chlamydia trachomatis /Neisseria gonorrhoea/Trichomonas vaginalis infection.

resultsOf 1396 study participants, 65.4% were women, the median age was 29 (IQR 23-36) years, and 19.6% were known HIV-positive. Overall, 68.6% had symptoms suggestive of Chlamydia trachomatis /Neisseria gonorrhoea/Trichomonas vaginalis infections. Laboratory-confirmed Chlamydia trachomatis /Neisseria gonorrhoea/Trichomonas vaginalis infection was found in 31.7% (n = 443/1396), of whom 20.8% were asymptomatic. Combined Chlamydia trachomatis /Neisseria gonorrhoea/Trichomonas vaginalis infections were common even among individuals with low risk of infection (e.g., no sexual intercourse: 20.7%) and were associated with young age, factory employment, and transactional sex. Prevalences for individual sexually transmitted infections were 16.9% (n = 236/1394) for Chlamydia trachomatis , 12.4% (n = 173/1394) for Neisseria gonorrhoea, 10.6% (n = 148/1390) for Trichomonas vaginalis, and 9.7% (n = 135) for Treponema pallidum . Viral infections were high for herpes simplex 2 viruses (n = 792/1279, 61.9%) and human papillomavirus (n = 166/324, 51.2%) and lower for hepatitis B virus (n = 55/1396, 3.9%) and hepatitis C virus (n = 3/1396, 0.2%). Of 1122 clients undergoing HIV testing, 4.1% (n = 46/1122) tested positive, with 21.7% (n = 10/46) being acute/early HIV infection.

conclusionsThe substantial sexually transmitted infections burden highlights the urgent need to strengthen sexually transmitted infections service integration, expand access to affordable diagnostics, and target prevention in decentralised care. These findings support the development of context-adapted strategies to improve detection, treatment, and partner services in high-burden settings.

Indexed as

Asymptomatic InfectionsCoinfectionCost of IllnessHIV InfectionsSexually Transmitted DiseasesAdolescentAdultChlamydia trachomatisCross-Sectional StudiesEswatiniFemaleHerpesvirus 2, HumanHuman Papillomavirus VirusesHumansMaleMiddle AgedchlamydiagonorrhoeahepatitisHPVHSV‐2STI

Identifiers

PMID40695730
PMCPMC12401637

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.